{ "company_number": "08077110", "name": "Regenerus Laboratories Limited", "url": "/company/08077110", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2012-05-21", "dissolved_on": null, "sic_codes": [ { "code": "86900", "description": "Other human health activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86900" } ], "registered_address": { "id": 187248, "url": "/address/187248", "line1": "78 YORK STREET", "line2": "", "post_town": "LONDON", "county": "", "country": "ENGLAND", "postcode": "W1H 1DP" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08077110", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-02-28", "last_made_up": "2025-05-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/08077110/accounts/2025-05-31", "pdf_url": "/company/08077110/accounts/2025-05-31.pdf", "made_up_date": "2025-05-31", "period_start": "2025-05-31", "period_end": "2025-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": "0.17", "tangible_fixed_assets": "47853.00", "debtors": "2227310.00", "cash_bank_in_hand": "63920.00", "current_assets": "2293186.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1261721.00", "total_assets_less_current_liabilities": "1309574.00", "net_assets_liabilities": "1304650.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2025.zip" }, { "url": "/company/08077110/accounts/2024-05-31", "pdf_url": "/company/08077110/accounts/2024-05-31.pdf", "made_up_date": "2024-05-31", "period_start": "2024-05-31", "period_end": "2024-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": "17.00", "tangible_fixed_assets": "45612.00", "debtors": "1090739.00", "cash_bank_in_hand": "538660.00", "current_assets": "1638549.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "495541.00", "total_assets_less_current_liabilities": "541153.00", "net_assets_liabilities": "536599.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2025.zip" }, { "url": "/company/08077110/accounts/2023-05-31", "pdf_url": "/company/08077110/accounts/2023-05-31.pdf", "made_up_date": "2023-05-31", "period_start": "2023-05-31", "period_end": "2023-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": "19.00", "tangible_fixed_assets": "36413.00", "debtors": "306318.00", "cash_bank_in_hand": "376034.00", "current_assets": "689852.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "30650.00", "total_assets_less_current_liabilities": "67063.00", "net_assets_liabilities": "16817.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2024.zip" }, { "url": "/company/08077110/accounts/2022-05-31", "pdf_url": "/company/08077110/accounts/2022-05-31.pdf", "made_up_date": "2022-05-31", "period_start": "2022-05-31", "period_end": "2022-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": "10.00", "tangible_fixed_assets": "26173.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "392948.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "111144.00", "total_assets_less_current_liabilities": "137317.00", "net_assets_liabilities": "137317.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "137317.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2022.zip" }, { "url": "/company/08077110/accounts/2021-05-31", "pdf_url": "/company/08077110/accounts/2021-05-31.pdf", "made_up_date": "2021-05-31", "period_start": "2021-05-31", "period_end": "2021-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "10577.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "302472.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "56790.00", "total_assets_less_current_liabilities": "67367.00", "net_assets_liabilities": "21528.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "21528.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2021.zip" }, { "url": "/company/08077110/accounts/2020-05-31", "pdf_url": "/company/08077110/accounts/2020-05-31.pdf", "made_up_date": "2020-05-31", "period_start": "2020-05-31", "period_end": "2020-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "5847.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "179441.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-119886.00", "total_assets_less_current_liabilities": "-114039.00", "net_assets_liabilities": "-189976.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-189976.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2021.zip" }, { "url": "/company/08077110/accounts/2019-05-31", "pdf_url": "/company/08077110/accounts/2019-05-31.pdf", "made_up_date": "2019-05-31", "period_start": "2019-05-31", "period_end": "2019-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "18181.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "150175.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-173050.00", "total_assets_less_current_liabilities": "-154869.00", "net_assets_liabilities": "-196600.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-196600.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2020.zip" }, { "url": "/company/08077110/accounts/2018-05-31", "pdf_url": "/company/08077110/accounts/2018-05-31.pdf", "made_up_date": "2018-05-31", "period_start": "2018-05-31", "period_end": "2018-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "37627.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-18825.00", "total_assets_less_current_liabilities": "18802.00", "net_assets_liabilities": "-53500.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-53500.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2019.zip" }, { "url": "/company/08077110/accounts/2017-05-31", "pdf_url": "/company/08077110/accounts/2017-05-31.pdf", "made_up_date": "2017-05-31", "period_start": "2017-05-31", "period_end": "2017-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "36078.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "115769.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "25625.00", "total_assets_less_current_liabilities": "61703.00", "net_assets_liabilities": "14337.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "14337.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2017.zip" }, { "url": "/company/08077110/accounts/2016-05-31", "pdf_url": "/company/08077110/accounts/2016-05-31.pdf", "made_up_date": "2016-05-31", "period_start": "2016-05-31", "period_end": "2016-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "36626.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "105818.00", "creditors_due_within_one_year": "112624.00", "creditors_due_after_one_year": "27123.00", "net_current_assets_liabilities": "-6806.00", "total_assets_less_current_liabilities": "29820.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2697.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2017.zip" }, { "url": "/company/08077110/accounts/2015-05-31", "pdf_url": "/company/08077110/accounts/2015-05-31.pdf", "made_up_date": "2015-05-31", "period_start": "2015-05-31", "period_end": "2015-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "4619.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "117768.00", "creditors_due_within_one_year": "60837.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "56931.00", "total_assets_less_current_liabilities": "61550.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "61550.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2016.zip" }, { "url": "/company/08077110/accounts/2014-05-31", "pdf_url": "/company/08077110/accounts/2014-05-31.pdf", "made_up_date": "2014-05-31", "period_start": "2014-05-31", "period_end": "2014-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "2210.00", "debtors": "72150.00", "cash_bank_in_hand": "12144.00", "current_assets": "84794.00", "creditors_due_within_one_year": "25101.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "59693.00", "total_assets_less_current_liabilities": "61903.00", "net_assets_liabilities": null, "called_up_share_capital": "1000.00", "profit_loss_account_reserve": "36153.00", "shareholder_funds": "61903.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2015.zip" }, { "url": "/company/08077110/accounts/2013-05-31", "pdf_url": "/company/08077110/accounts/2013-05-31.pdf", "made_up_date": "2013-05-31", "period_start": "2013-05-31", "period_end": "2013-05-31", "entity_name": "Regenerus Laboratories Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "568.00", "debtors": "35691.00", "cash_bank_in_hand": "5521.00", "current_assets": "41752.00", "creditors_due_within_one_year": "12692.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "29060.00", "total_assets_less_current_liabilities": "29628.00", "net_assets_liabilities": null, "called_up_share_capital": "1000.00", "profit_loss_account_reserve": "3878.00", "shareholder_funds": "29628.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2014.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08077110/filing-history" }, "confirmation_statement": { "next_due": "2027-07-08", "last_made_up": "2026-06-24" }, "officers": [], "psc": [ { "name": "Mrs Emma Lucy Price", "kind": "individual-person-with-significant-control", "person_url": "/person/1474113", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2022-08-08", "ceased_on": "2023-05-27", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Justin Chandler Hilton Price", "kind": "individual-person-with-significant-control", "person_url": "/person/2545441", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2023-05-27", "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Regenerus Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/SC624782", "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2023-05-27", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-29T21:05:51.028561+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }